Potentiation of the action of anandamide on hippocampal slices by the fatty acid amide hydrolase inhibitor, palmitylsulphonyl fluoride (AM 374)

Citation
An. Gifford et al., Potentiation of the action of anandamide on hippocampal slices by the fatty acid amide hydrolase inhibitor, palmitylsulphonyl fluoride (AM 374), EUR J PHARM, 383(1), 1999, pp. 9-14
Citations number
18
Categorie Soggetti
Pharmacology & Toxicology
Journal title
EUROPEAN JOURNAL OF PHARMACOLOGY
ISSN journal
00142999 → ACNP
Volume
383
Issue
1
Year of publication
1999
Pages
9 - 14
Database
ISI
SICI code
0014-2999(19991021)383:1<9:POTAOA>2.0.ZU;2-K
Abstract
The electrically-evoked release of [H-3]acetylcholine from hippocampal brai n slices is inhibited by cannabinoid receptor agonists. The effect of palmi tylsulphonyl fluoride (AM 374), a recently developed inhibitor of fatty aci d amide hydrolase, in influencing the potency of exogenously added anandami de in this preparation was examined. Anandamide alone had relatively Little effect on [H-3]acetylcholine release. By contrast, in the presence of AM 3 74 (0.1 mu M), anandamide produced a significant inhibition of [H-3]acetylc holine release at all concentrations tested (0.1-10 mu M). In addition to e xperiments with AM 374 the effects of N-(4-hydroxyphenyl)arachidonamide (AM 404), a putative anandamide uptake inhibitor, was also examined. However, AM 404 at concentrations up to 10 mu M, was not found to significantly enha nce the effect of anandamide on electrically-evoked [H-3]acetylcholine rele ase. These results indicate that AM 374 potently inhibits endogenous amidas e activity and thus facilitates access of exogenous anandamide to cannabino id receptors in the hippocampal tissue. (C) 1999 Elsevier Science B.V. All rights reserved.